Superior Anticancer Potential of Nano-Paclitaxel Combined Bevacizumab Treatment in Ovarian Cancer.
Curr Pharm Biotechnol
; 24(9): 1204-1212, 2023.
Article
in En
| MEDLINE
| ID: mdl-36221878
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Ovarian Neoplasms
/
Paclitaxel
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Curr Pharm Biotechnol
Journal subject:
BIOTECNOLOGIA
/
FARMACOLOGIA
Year:
2023
Document type:
Article
Affiliation country:
China
Country of publication:
Netherlands